These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 17336590

  • 1. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, Molnár T, Lonovics J, Garcia-Villar R, Fioramonti J, Wittmann T, Bueno L.
    Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
    [Abstract] [Full Text] [Related]

  • 2. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.
    Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztóczy A, Izbéki F, Fioramonti J, Wittmann T, Bueno L.
    Gut; 2008 May; 57(5):591-9. PubMed ID: 18194983
    [Abstract] [Full Text] [Related]

  • 3. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice.
    Annaházi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztóczy A, Róka R, Molnár T, Theodorou V, Wittmann T, Bueno L, Eutamene H.
    Pain; 2009 Jul; 144(1-2):209-17. PubMed ID: 19450926
    [Abstract] [Full Text] [Related]

  • 4. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M.
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [Abstract] [Full Text] [Related]

  • 5. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
    Gecse K, Róka R, Séra T, Rosztóczy A, Annaházi A, Izbéki F, Nagy F, Molnár T, Szepes Z, Pávics L, Bueno L, Wittmann T.
    Digestion; 2012 Oct; 85(1):40-6. PubMed ID: 22179430
    [Abstract] [Full Text] [Related]

  • 6. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J, Junge A, Rueffer A, Wehkamp J, Foell D, Michalsen A, Musial F, Dobos GJ.
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [Abstract] [Full Text] [Related]

  • 7. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
    Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC.
    Am J Gastroenterol; 2006 Jun; 101(6):1288-94. PubMed ID: 16771951
    [Abstract] [Full Text] [Related]

  • 8. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
    Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB.
    Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
    [Abstract] [Full Text] [Related]

  • 9. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
    Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G.
    Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
    [Abstract] [Full Text] [Related]

  • 10. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
    Li MR, Jiang K, Zhang QY.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):957-60. PubMed ID: 18756966
    [Abstract] [Full Text] [Related]

  • 11. Colonic proteinases: increased activity in patients with ulcerative colitis.
    Bustos D, Negri G, De Paula JA, Di Carlo M, Yapur V, Facente A, De Paula A.
    Medicina (B Aires); 1998 Apr 08; 58(3):262-4. PubMed ID: 9713093
    [Abstract] [Full Text] [Related]

  • 12. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA.
    Gastroenterology; 2006 Jan 08; 130(1):34-43. PubMed ID: 16401466
    [Abstract] [Full Text] [Related]

  • 13. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC.
    J Gastroenterol Hepatol; 2006 Jan 08; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.
    Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A.
    Am J Gastroenterol; 2005 Feb 08; 100(2):373-82. PubMed ID: 15667495
    [Abstract] [Full Text] [Related]

  • 15. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW.
    J Gastroenterol Hepatol; 2008 Nov 08; 23(11):1689-94. PubMed ID: 19120860
    [Abstract] [Full Text] [Related]

  • 16. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis.
    Lettesjö H, Hansson T, Peterson C, Ung KA, Ringström G, Abrahamsson H, Simrén M.
    Scand J Gastroenterol; 2006 Jan 08; 41(1):54-9. PubMed ID: 16373277
    [Abstract] [Full Text] [Related]

  • 17. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
    Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, Sokol H, Coffin B, Sabaté JM.
    Neurogastroenterol Motil; 2012 Jun 08; 24(6):513-20, e246-7. PubMed ID: 22356587
    [Abstract] [Full Text] [Related]

  • 18. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan 08; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 19. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H, Küppers B, Mickisch O, Baniewicz W, Drescher M, Traber L, Kempf A, Schmidt-Gayk H.
    Clin Lab; 2005 Jan 08; 51(3-4):117-26. PubMed ID: 15819166
    [Abstract] [Full Text] [Related]

  • 20. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY, Huang SG, Zhang HY, Ye H, Chi HG, Zou Y, Lv RX, Zheng XB.
    World J Gastroenterol; 2016 Mar 28; 22(12):3451-9. PubMed ID: 27022227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.